Knowing the MSI status of a tumor can have significant clinical implications. MSI-high (MSI-H) tumors often have a better prognosis compared to microsatellite stable (MSS) tumors. Additionally, MSI status can influence treatment strategies. For instance, MSI-H colorectal cancers are less likely to respond to traditional chemotherapy but may respond well to immunotherapy, such as checkpoint inhibitors.
